Articles on Prion, Amyloidogenic, Amyloid, Tau or other Protein Involvement in Long Covid and Covid-19
"Prion propensity of Betacoronaviruses including SARS-CoV-2"
"Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2"
https://pmc.ncbi.nlm.nih.gov/articles/PMC10047479/
"Amyloidogenesis of SARS-CoV-2 Spike Protein"
https://pubs.acs.org/doi/10.1021/jacs.2c03925
https://pubs.acs.org/doi/10.1021/jacs.2c03925
"A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review"
https://pmc.ncbi.nlm.nih.gov/articles/PMC9922164/
"Prion Disease After COVID-19: A Case Report"
"Sars-cov-2 Invasion And Pathological Links To Prion Disease"
https://digitalscholar.lsuhsc.edu/context/som_facpubs/article/1583/viewcontent/SarsCov2InvasionAndPathologicalLinksToPrionDisease_20220907.pdf
https://www.mdpi.com/2218-273X/12/9/1253
https://digitalscholar.lsuhsc.edu/context/som_facpubs/article/1583/viewcontent/SarsCov2InvasionAndPathologicalLinksToPrionDisease_20220907.pdf
https://www.mdpi.com/2218-273X/12/9/1253
"SARS-CoV-2, long COVID, prion disease and neurodegeneration"
https://pmc.ncbi.nlm.nih.gov/articles/PMC9551214/
https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.1002770/full
"The Prion hypothesis about Long Covid and SARS-CoV-2"
https://www.researchgate.net/publication/366355790_The_Prion_hypothesis_about_Long_Covid_and_SARS-CoV-2
https://www.researchgate.net/publication/366355790_The_Prion_hypothesis_about_Long_Covid_and_SARS-CoV-2
"COVID-19 RNA Based Vaccines and the Risk of Prion Disease"
https://scivisionpub.com/pdfs/covid19-rna-based-vaccines-and-the-risk-of-prion-disease-1503.pdf
"SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2"
https://www.preprints.org/manuscript/202003.0422/v1
https://www.preprints.org/manuscript/202003.0422/v1
"Highly efficient intercellular spreading of protein misfolding mediated by
viral ligand-receptor interactions"
https://www.nature.com/articles/s41467-021-25855-2
"Tau protein aggregation associated with SARS-CoV-2 main protease"
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288138
"Amyloidogenesis of SARS-CoV-2 Spike Protein"
https://pubs.acs.org/doi/10.1021/jacs.2c03925
https://pubs.acs.org/doi/10.1021/jacs.2c03925
"SARS-CoV-2 N-protein induces the formation of composite α-synuclein/N-protein
fibrils that transform into a strain of α-synuclein fibrils"
https://pubs.rsc.org/en/content/articlelanding/2023/nr/d3nr03556e
"Amyloidogenic proteins in the SARS-CoV and SARS-CoV- proteomes"
"Structural dynamics of single SARS-CoV-2 pseudoknot molecules reveal topologically
distinct conformers"
https://www.nature.com/articles/s41467-021-25085-6
distinct conformers"
https://www.nature.com/articles/s41467-021-25085-6
"Creutzfeldt Jakob Disease Associated with E200K Mutation and SARS-CoV-2 Infection: Pure Coincidence or Neurodegenerative Acceleration?"
https://www.mdpi.com/2514-183X/8/2/16
"Long COVID as a Tauopathy: Of Brain Fog and Fusogen Storms"
https://www.mdpi.com/1422-0067/24/16/12648
***bioRxiv articles****
"SARS-CoV-2 Spike amyloid fibrils specifically and selectively acceleratesamyloid fibril formation of human prion protein and the amyloid β peptide"
https://www.biorxiv.org/content/10.1101/2023.09.01.555834v1
"Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2:
Potential Implications for Neurological Symptoms in COVID-19"
https://www.biorxiv.org/content/10.1101/2021.11.24.469537v1
"Proteomic evidence for amyloidogenic cross-seeding in fibrinaloid microclots"
https://www.biorxiv.org/content/10.1101/2024.07.16.603837v1
"SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF
Resulting in Drastic Soluble Protein Depletion"
https://www.biorxiv.org/content/10.1101/2022.09.15.508120v2
"An amyloidogenic fragment of the SARS CoV-2 envelope protein
promotes serum amyloid A misfolding and fibrillization"
https://www.biorxiv.org/content/10.1101/2024.04.25.591137v1
"Cell invasive amyloid assemblies from SARS-CoV-2 peptides
can form multiple polymorphs with varying neurotoxicity"
https://www.biorxiv.org/content/10.1101/2024.05.16.594465v1
"Peptide from NSP7 is able to form amyloid-like fibrils:
artifact or challenge to drug design?"
https://www.biorxiv.org/content/10.1101/2022.06.28.497929v1
"Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form
multiple polymorphs with varying neurotoxicity"
https://www.biorxiv.org/content/10.1101/2024.05.16.594465v1
"Presence of a SARS-COV-2 protein enhances Amyloid Formation of Serum Amyloid A"
https://www.biorxiv.org/content/10.1101/2021.05.18.444723v2
"Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2"
https://www.biorxiv.org/content/10.1101/2021.03.05.434000v2
No comments:
Post a Comment
Moderated Comments: Be polite and quantitative in your remarks. Just because I am not always so doesn't mean you will get your commentary published.